Juliana Tablet contains a combination of Ethinyl Estradiol (0.02 mg) and Desogestrel (0.15 mg), which are synthetic hormones used primarily for oral contraception. Ethinyl Estradiol is a synthetic estrogen, while Desogestrel is a progestin; together, they work by inhibiting ovulation, altering the cervical mucus to prevent sperm penetration, and modifying the endometrial lining to reduce the likelihood of implantation. Juliana Tablet is indicated for the prevention of pregnancy in women seeking reliable contraceptive methods. It is administered orally, typically once daily at the same time each day, to maintain consistent hormone levels and maximize efficacy. The combination is generally well-tolerated, but users should be aware of potential side effects such as nausea, headache, breast tenderness, and changes in menstrual bleeding patterns. Contraindications include a history of thromboembolic disorders, hormone-sensitive malignancies, liver disease, and unexplained vaginal bleeding. Prior to initiation, a thorough medical history and risk assessment are essential. Juliana Tablet does not protect against sexually transmitted infections. Patients should be counseled on adherence and advised to consult healthcare providers if adverse reactions or contraindications arise. This medication should be used under medical supervision to ensure safety and effectiveness.